MedCity Influencers, BioPharma

Why medication management reform must be a priority for the new administration

The Biden administration should recognize that including high quality, patient-centered comprehensive medication management (CMM) services as the national standard of care will improve patient outcomes, reduce health care costs and save lives.

As the Biden administration transitions into governance, all eyes are on the policies they will enact in a number of key areas, no doubt healthcare being one of them. While the administration is eager to make a difference in the lives of all Americans, it should recognize the need for medication management reform.

A crucial opportunity is at hand to embolden health care strategy by ensuring patients understand their medications and are able to work with a clinical pharmacist and their physician to verify the medicines prescribed are right for them. With over 10,000 drugs on the market today, appropriate, effective, safe and precise use of medication and gene therapies is more important now than ever before. Including high quality, patient-centered comprehensive medication management (CMM) services as the national standard of care will improve patient outcomes, reduce health care costs and save lives.

sponsored content

Integrated Enrollment Platforms and Consumer Assistance Centers: The Strongest Advantage for State-Based Exchanges

In the ever-evolving landscape of state-based health insurance exchanges, the convergence of technology and customer service is reshaping how these exchanges operate. The increasing advent of automation and artificial intelligence (AI) is rapidly dismantling the traditional business model that relies on the siloing of technology and customer service centers.

CMM is a team-based care solution with the patient working in concert with a physician and a team of other health providers including a clinical pharmacist. A comprehensive interprofessional team leverages the skills and expertise of each member to achieve optimized medication use. Each medication is evaluated to ensure it is appropriate for the patient, effective for the medical condition, safe with the patient’s other medications and can be taken by the patient as prescribed.

With an overtaxed health system fighting Covid-19 nationwide, physician appointments, emergency room availability and hospital beds are in short supply. Data show that improper medication therapy (misuse, underuse and overuse) can result in treatment failure, new medical problems or both. Annually 275,000 avoidable deaths and health costs of $528.4 billion are the results of non-optimized medication use.

Studies reveal that CMM reduces the drain on the health care system by improving clinical outcomes and reducing hospital readmission rates.  Now is the ideal time for the Biden administration to effect significant policy change through a team-based care strategy focused on getting the medications right for patients.

How should the administration implement comprehensive medication management reform? The following five principles should be considered:

  • Develop a patient-focused, personalized, systematic, structured approach that will optimize medication use through CMM in practice to significantly improve patient health outcomes, lower health care costs and save lives.
  • Integrate CMM within systems of care by incorporating patients in the health care process to ensure they agree to the medication plan and are able to take them as directed for optimum outcomes.
  • Streamline and lower costs associated with clinical trials and bring drugs to market through delivery system, payment and policy change while implementing widespread adoption of CMM.
  • Expand resources available including access to advanced diagnostics such as companion/complementary and pharmacogenomics (PGx) testing to target correct therapies during the CMM process.
  • Adopt payment models that recognize interprofessional team-based care including clinical pharmacists working in collaborative practice with physicians and other providers.

With a pandemic ravaging our nation, an opioid epidemic devastating too many lives, diabetes and heart disease diagnoses plaguing young and old and other long-term illnesses affecting Americans every day, the U.S. must implement a national CMM health care strategy to get the medications right. As the Biden administration works to reform the broken healthcare process, this proven team-based patient care approach to medication management should be the cornerstone of its new policies.

Photo: Stuart Ritchie, Getty Images

As executive director, Katherine Capps provides leadership by supporting GTMRx Institute’s mission and goals. She establishes and manages relationships with stakeholders across the health care spectrum. As a GTMR Institute Founding Board member, she works alongside other board members and collaboratively sets the strategy for the growth and activities of the organization.

Katie has a long history of collaboration in multi-stakeholder environments. As Health2 Resources’ founder and president, she and her team have helped more than 35 clients meet advocacy, policy, outreach, marketing and awareness goals. H2R was instrumental in the launch of the Patient-Centered Primary Care Collaborative, lending expertise for organizational development and marketing and communications.

She has served on the board of the Washington Adventist Health Foundation, the Institute for Health and Productivity Management (advisory board), the Healthcare Industry Access Initiative and Emmi Solutions. She has served on the board of the National Business Coalition on Health and its national advisory board, and on the NCQA purchaser committee. She writes on topics relating to quality, health care cost, market-based health care reform and the value of shared health information.

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.